{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:42:16Z","timestamp":1771533736104,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,7,31]],"date-time":"2011-07-31T00:00:00Z","timestamp":1312070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00296-011-2008-6","type":"journal-article","created":{"date-parts":[[2011,7,30]],"date-time":"2011-07-30T08:51:41Z","timestamp":1312015901000},"page":"287-294","source":"Crossref","is-referenced-by-count":22,"title":["The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review"],"prefix":"10.1007","volume":"32","author":[{"given":"Christos G.","family":"Mihos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa T.","family":"Artola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando","family":"Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,31]]},"reference":[{"key":"2008_CR1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.321.7267.983","volume":"321","author":"M Pignone","year":"2000","unstructured":"Pignone M, Phillips C, Mulrow C (2000) Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomized trials. BMJ. 321:983\u2013985","journal-title":"BMJ."},{"key":"2008_CR2","unstructured":"Tonkin A, Aylward P, Colquhoun D et al. (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group. N Engl J Med 339(19):1349\u20131357"},{"issue":"9","key":"2008_CR3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.jcbfm.9600116","volume":"25","author":"M Endres","year":"2005","unstructured":"Endres M (2005) Statins and stroke. J Cereb Blood Flow Metab 25(9):1093\u20131110","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2008_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0167-5273(02)00195-X","volume":"86","author":"JK Liao","year":"2002","unstructured":"Liao JK (2002) Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol 86(1):5\u201318","journal-title":"Int J Cardiol"},{"issue":"1","key":"2008_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1755-5922.2009.00103.x","volume":"28","author":"J Li","year":"2010","unstructured":"Li J, Li JJ, He JG, Nan JL, Guo YL, Xiong CM (2010) Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappa B pathway. Cardiovasc Ther 28(1):8\u201314","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"2008_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0253-7613.15106","volume":"37","author":"V Tandon","year":"2005","unstructured":"Tandon V, Bano G, Khajuria V, Parihar A, Gupta S (2005) Pleiotropic effects of statins. Indian J Pharmacol 37(2):77\u201385","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"2008_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/03009740802572475","volume":"38","author":"S Blaschke","year":"2009","unstructured":"Blaschke S, Viereck V, Schwarz G, Klinger HM, Guerluek S, M\u00fcller GA (2009) Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis. Scand J Rheumatol 38(4):235\u2013239","journal-title":"Scand J Rheumatol"},{"key":"2008_CR8","unstructured":"Lazzerini PE, Lorenzini S, Selvi E et al. (2007) Simvastatin inhibits cytokine production and nuclear factor-k B activation in interleukin 1-beta stimulated synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 25(5):696\u2013700"},{"issue":"11","key":"2008_CR9","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1002\/art.22169","volume":"54","author":"H Xu","year":"2006","unstructured":"Xu H, Liu P, Liang L et al (2006) RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin. Arthritis Rheum 54(11):3441\u20133451","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2008_CR10","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar1968","volume":"8","author":"AM Connor","year":"2006","unstructured":"Connor AM, Berger S, Narendran A, Keystone EC (2006) Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts. Arthritis Res Ther 8(4):R94","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2008_CR11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.21564","volume":"54","author":"T Nagashima","year":"2006","unstructured":"Nagashima T, Okazaki H, Yudoh K, Matsuno H, Minota S (2006) Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Arthritis Rheum 54(2):579\u2013586","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2008_CR12","first-page":"193","volume":"35","author":"K Yokota","year":"2008","unstructured":"Yokota K, Miyoshi F, Miyazaki T et al (2008) High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 35(2):193\u2013200","journal-title":"J Rheumatol"},{"issue":"11","key":"2008_CR13","first-page":"2095","volume":"32","author":"C Tikiz","year":"2005","unstructured":"Tikiz C, Utuk O, Pirildar T et al (2005) Effects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with long-term rheumatoid arthritis. J Rheumatol 32(11):2095\u20132101","journal-title":"J Rheumatol"},{"issue":"6","key":"2008_CR14","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/art.22632","volume":"56","author":"Y Haruna","year":"2007","unstructured":"Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N (2007) Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis Rheum 56(6):1827\u20131835","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2008_CR15","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar2019","volume":"8","author":"AR Kinderlerer","year":"2006","unstructured":"Kinderlerer AR, Steinberg R, Johns M et al (2006) Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis. Arthritis Res Ther 8(4):R130","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"2008_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.RES.0000202706.70992.95","volume":"98","author":"R Paumelle","year":"2006","unstructured":"Paumelle R, Blanquart C, Briand O et al (2006) Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res 98(3):361\u2013369","journal-title":"Circ Res"},{"key":"2008_CR17","doi-asserted-by":"crossref","unstructured":"Lin H, Xiao Y, Chen G et al. (2010) HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients. Rheumatol Int. 15 May 2010. (in press)","DOI":"10.1007\/s00296-010-1510-6"},{"issue":"6","key":"2008_CR18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","volume":"7","author":"G Weitz-Schmidt","year":"2001","unstructured":"Weitz-Schmidt G, Welzenbach K, Brinkmann V et al (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7(6):687\u2013692","journal-title":"Nat Med"},{"issue":"9426","key":"2008_CR19","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","volume":"363","author":"DW McCarey","year":"2004","unstructured":"McCarey DW, McInnes IB, Madhok R et al (2004) Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized placebo-controlled trial. Lancet 363(9426):2015\u20132021","journal-title":"Lancet"},{"issue":"1","key":"2008_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/03009740802363776","volume":"38","author":"IV Shirinsky","year":"2009","unstructured":"Shirinsky IV, Zheltova OI, Solovyova NY, Kozlov VA (2009) Shirinsky versus changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment. Scand J Rheumatol 38(1):23\u201327","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"2008_CR21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","volume":"50","author":"KM M\u00e4ki-Pet\u00e4j\u00e4","year":"2007","unstructured":"M\u00e4ki-Pet\u00e4j\u00e4 KM, Booth AD, Hall FC et al (2007) Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 50(9):852\u2013858","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2008_CR22","first-page":"964","volume":"34","author":"H Okamoto","year":"2007","unstructured":"Okamoto H, Koizumi K, Kamitsuji S et al (2007) Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort. J Rheumatol 34(5):964\u2013968","journal-title":"J Rheumatol"},{"issue":"1","key":"2008_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00019053-200927010-00004","volume":"27","author":"N Bansback","year":"2009","unstructured":"Bansback N, Ara R, Ward S, Anis A, Choi HK (2009) Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis. Pharmacoeconomics 27(1):25\u201337","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"2008_CR24","doi-asserted-by":"crossref","first-page":"e1000336","DOI":"10.1371\/journal.pmed.1000336","volume":"7","author":"G Chodick","year":"2010","unstructured":"Chodick G, Amital H, Shalem Y et al (2010) Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study. PLoS Med 7(9):e1000336","journal-title":"PLoS Med"},{"issue":"4","key":"2008_CR25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/ard.2008.091967","volume":"68","author":"SS Jick","year":"2009","unstructured":"Jick SS, Choi H, Li L, McInnes IB, Sattar N (2009) Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Ann Rheum Dis 68(4):546\u2013551","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2008_CR26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10654-004-1706-8","volume":"19","author":"P Orozco","year":"2004","unstructured":"Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19(12):1105\u20131112","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"2008_CR27","first-page":"581","volume":"23","author":"R Hanayama","year":"2009","unstructured":"Hanayama R, Shimizu H, Nakagami H et al (2009) Fluvastatin improves osteoporosis in fructose-fed insulin resistant model rats through blockade of the classical mevalonate pathway and antioxidant action. Int J Mol Med 23(5):581\u2013588","journal-title":"Int J Mol Med"},{"issue":"8","key":"2008_CR28","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/ijc.23745","volume":"123","author":"KS Ahn","year":"2008","unstructured":"Ahn KS, Sethi G, Chaturvedi MM, Aggarwal BB (2008) Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int J Cancer 123(8):1733\u20131740","journal-title":"Int J Cancer"},{"issue":"1","key":"2008_CR29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1359\/jbmr.2003.18.1.88","volume":"18","author":"A Staal","year":"2003","unstructured":"Staal A, Frith JC, French MH et al (2003) The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res 18(1):88\u201396","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2008_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nutres.2010.03.004","volume":"30","author":"PY Chen","year":"2010","unstructured":"Chen PY, Sun JS, Tsuang YH, Chen MH, Weng PW, Lin FH (2010) Simvastatin promotes osteoblast viability and differentiation via Ras\/Smad\/Erk\/BMP-2 signaling pathway. Nutr Res 30(3):191\u2013199","journal-title":"Nutr Res"},{"issue":"3","key":"2008_CR31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jcb.20074","volume":"92","author":"T Maeda","year":"2004","unstructured":"Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N (2004) Induction of osteoblast differentiation indices by statins in MC3T3\u2013E1 cells. J Cell Biochem 92(3):458\u2013471","journal-title":"J Cell Biochem"},{"key":"2008_CR32","doi-asserted-by":"crossref","unstructured":"Li X, Cui Q, Kao C, Wang GJ, Balian G (2003) Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1\/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33(4):652\u2013659","DOI":"10.1016\/S8756-3282(03)00239-4"},{"issue":"9","key":"2008_CR33","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1210\/jc.86.9.4556","volume":"86","author":"MH Chan","year":"2001","unstructured":"Chan MH, Mak TW, Chiu RW, Chow CC, Chan IH, Lam CW (2001) Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolemia. J Clin Endocrinol Metab 86(9):4556\u20134559","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2008_CR34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.maturitas.2009.03.018","volume":"63","author":"Y Uyar","year":"2009","unstructured":"Uyar Y, Baytur Y, Inceboz U, Demir BC, Gumuser G, Ozbilgin K (2009) Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. Maturitas 63(3):261\u2013267","journal-title":"Maturitas"},{"issue":"2","key":"2008_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0501.2008.01630.x","volume":"20","author":"Z Du","year":"2009","unstructured":"Du Z, Chen J, Yan F, Xiao Y (2009) Effects of simvastatin on bone healing around titanium implants in osteoporotic rats. Clin Oral Implants Res 20(2):145\u2013150","journal-title":"Clin Oral Implants Res"},{"issue":"12","key":"2008_CR36","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00198-007-0412-2","volume":"18","author":"JW Wang","year":"2007","unstructured":"Wang JW, Xu SW, Yang DS, Lv RK (2007) Locally applied simvastatin promotes fracture healing in ovariectomized rat. Osteoporos Int 18(12):1641\u20131650","journal-title":"Osteoporos Int"},{"issue":"8","key":"2008_CR37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00198-004-1793-0","volume":"16","author":"C Hatzigeorgiou","year":"2005","unstructured":"Hatzigeorgiou C, Jackson JL (2005) Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis. Osteoporos Int 16(8):990\u2013998","journal-title":"Osteoporos Int"},{"issue":"6","key":"2008_CR38","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","volume":"40","author":"B Uzzan","year":"2007","unstructured":"Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2007) Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 40(6):1581\u20131587","journal-title":"Bone"},{"issue":"5","key":"2008_CR39","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/gme.0b013e3181d3e036","volume":"17","author":"J Yue","year":"2010","unstructured":"Yue J, Zhang X, Dong B, Yang M (2010) Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials. Menopause 17(5):1071\u20131079","journal-title":"Menopause"},{"issue":"2","key":"2008_CR40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archinte.164.2.146","volume":"164","author":"DC Bauer","year":"2004","unstructured":"Bauer DC, Mundy GR, Jamal SA et al (2004) Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med 164(2):146\u2013152","journal-title":"Arch Intern Med"},{"issue":"2","key":"2008_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000170886","volume":"53","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2008","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Vega G, Abad L et al (2008) Effect of the TNFalpha-308 G\/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome. Ann Nutr Metab 53(2):117\u2013121","journal-title":"Ann Nutr Metab"},{"key":"2008_CR42","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Vega G, Abad L et al. (2009) Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene. Endocr J 56(2):221\u2013225"},{"issue":"9","key":"2008_CR43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1592\/phco.30.9.879","volume":"30","author":"LN Bakhireva","year":"2010","unstructured":"Bakhireva LN, Shainline MR, Carter S et al (2010) Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women. Pharmacotherapy 30(9):879\u2013887","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2008_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2004.08.007","volume":"120","author":"HA Tanriverdi","year":"2005","unstructured":"Tanriverdi HA, Barut A, Sarikaya S (2005) Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. Eur J Obstet Gynecol Reprod Biol 120(1):63\u201368","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"2008_CR45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/gye.17.4.329.332","volume":"17","author":"V Leo De","year":"2003","unstructured":"De Leo V, Morgante G, la Marca A, Lanzetta D, Cobellis L, Petraglia F (2003) Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density. Gynecol Endocrinol 17(4):329\u2013332","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"2008_CR46","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/art.27478","volume":"62","author":"H Amuro","year":"2010","unstructured":"Amuro H, Ito T, Miyamoto R et al (2010) Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Arthritis Rheum 62(7):2073\u20132085","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2008_CR47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0961203310364400","volume":"19","author":"GA Ferreira","year":"2010","unstructured":"Ferreira GA, Teixeira AL, Sato EI (2010) Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus. Lupus 19(8):927\u2013934","journal-title":"Lupus"},{"issue":"10","key":"2008_CR48","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.4049\/jimmunol.177.10.7416","volume":"177","author":"EC Jury","year":"2006","unstructured":"Jury EC, Isenberg DA, Mauri C, Ehrenstein MR (2006) Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. J Immunol 177(10):7416\u20137422","journal-title":"J Immunol"},{"issue":"2","key":"2008_CR49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clim.2010.03.008","volume":"136","author":"H Shimazu","year":"2010","unstructured":"Shimazu H, Kinoshita K, Hino S et al (2010) Effect of combining ACE inhibitor and statin in lupus-prone mice. Clin Immunol 136(2):188\u2013196","journal-title":"Clin Immunol"},{"issue":"3","key":"2008_CR50","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar3020","volume":"12","author":"JM Woo","year":"2010","unstructured":"Woo JM, Lin Z, Navab M et al (2010) Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis. Arthritis Res Ther 12(3):R93","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"2008_CR51","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.177.5.3028","volume":"177","author":"T Aprahamian","year":"2006","unstructured":"Aprahamian T, Bonegio R, Rizzo J et al (2006) Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J Immunol 177(5):3028\u20133034","journal-title":"J Immunol"},{"issue":"12","key":"2008_CR52","doi-asserted-by":"crossref","first-page":"7641","DOI":"10.4049\/jimmunol.173.12.7641","volume":"173","author":"S Lawman","year":"2004","unstructured":"Lawman S, Mauri C, Jury EC, Cook HT, Ehrenstein MR (2004) Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black\/white F1 mice. J Immunol 173(12):7641\u20137646","journal-title":"J Immunol"},{"key":"2008_CR53","unstructured":"Petri MA, Kiani AN, Post W, Christopher-Stine L, Magder LS (2010) Lupus atherosclerosis prevention study (LAPS). Ann Rheum Dis 70(5):760\u2013765"},{"issue":"10","key":"2008_CR54","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kem186","volume":"46","author":"GA Ferreira","year":"2007","unstructured":"Ferreira GA, Navarro TP, Telles RW, Andrade LE, Sato EI (2007) Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8\u00a0weeks controlled trial. Rheumatology (Oxford) 46(10):1560\u20131565","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2008_CR55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1191\/0961203305lu2189xx","volume":"14","author":"HM Belmont","year":"2005","unstructured":"Belmont HM, Lydon E (2005) Avascular necrosis prevention with lipitor in lupus erythematosus. Lupus 14(10):869\u2013870","journal-title":"Lupus"},{"issue":"7","key":"2008_CR56","first-page":"1323","volume":"35","author":"N Del Papa","year":"2008","unstructured":"Del Papa N, Cortiana M, Vitali C et al (2008) Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis. J Rheumatol 35(7):1323\u20131328","journal-title":"J Rheumatol"},{"key":"2008_CR57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1196\/annals.1423.070","volume":"1110","author":"A Abou-Raya","year":"2007","unstructured":"Abou-Raya A, Abou-Raya S, Helmii M (2007) Statins as immunomodulators in systemic sclerosis. Ann NY Acad Sci. 1110:670\u2013680","journal-title":"Ann NY Acad Sci."},{"issue":"6","key":"2008_CR58","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/01.bor.0000245720.02512.3e","volume":"18","author":"M Kuwana","year":"2006","unstructured":"Kuwana M (2006) Potential benefit of statins for vascular disease in systemic sclerosis. Curr Opin Rheumatol 18(6):594\u2013600","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"2008_CR59","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.21723","volume":"54","author":"N Louneva","year":"2006","unstructured":"Louneva N, Huaman G, Fertala J, Jim\u00e9nez SA (2006) Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum 54(4):1298\u20131308","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2008_CR60","first-page":"1801","volume":"35","author":"A Abou-Raya","year":"2008","unstructured":"Abou-Raya A, Abou-Raya S, Helmii M (2008) Statins: potentially useful in therapy of systemic sclerosis-related Raynaud\u2019s phenomenon and digital ulcers. J Rheumatol 35(9):1801\u20131808","journal-title":"J Rheumatol"},{"issue":"5","key":"2008_CR61","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s10165-009-0199-4","volume":"19","author":"M Kuwana","year":"2009","unstructured":"Kuwana M, Okazaki Y, Kaburaki J (2009) Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis. Mod Rheumatol 19(5):530\u2013535","journal-title":"Mod Rheumatol"},{"issue":"1","key":"2008_CR62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jor.20953","volume":"28","author":"T Simopoulou","year":"2010","unstructured":"Simopoulou T, Malizos KN, Poultsides L, Tsezou A (2010) Protective effect of atorvastatin in cultured osteoarthritic chondrocytes. J Orthop Res 28(1):110\u2013115","journal-title":"J Orthop Res"},{"issue":"7","key":"2008_CR63","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.joca.2010.03.015","volume":"18","author":"FM Sverdrup","year":"2010","unstructured":"Sverdrup FM, Yates MP, Vickery LE et al (2010) Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage. Osteoarthritis Cartilage 18(7):948\u2013955","journal-title":"Osteoarthritis Cartilage"},{"key":"2008_CR64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1874312900903010035","volume":"3","author":"I Litinsky","year":"2009","unstructured":"Litinsky I, Golan I, Yaron M, Yaron I, Caspi D, Elkayam O (2009) Simvastatin induces apoptosis of fibroblast-like synoviocytes. Open Rheumatol J. 3:35\u201340","journal-title":"Open Rheumatol J."},{"issue":"7","key":"2008_CR65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/ard.2003.009746","volume":"63","author":"PE Lazzerini","year":"2004","unstructured":"Lazzerini PE, Capecchi PL, Nerucci F et al (2004) Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture. Ann Rheum Dis 63(7):867\u2013869","journal-title":"Ann Rheum Dis"},{"key":"2008_CR66","doi-asserted-by":"crossref","unstructured":"Rabinowitz JL, Gregg JR, Nixon JE, Schumacher HR (1979) Lipid composition of the tissues of the human knee joints. I\u2014Observations in normal joints (articular cartilage, meniscus, ligaments, synovial fluid, synovium, intra-articular fat pad and bone marrow). Clin Orthop Relat Res (143):260\u2013265","DOI":"10.1097\/00003086-197909000-00041"},{"key":"2008_CR67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/BLO.0b013e31802cfa9e","volume":"456","author":"JW Pritchett","year":"2007","unstructured":"Pritchett JW (2007) Statins and dietary fish oils improve lipid composition in bone marrow and joints. Clin Orthop Relat Res. 456:233\u2013237","journal-title":"Clin Orthop Relat Res."},{"issue":"2","key":"2008_CR68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.joca.2008.06.012","volume":"17","author":"Y Akasaki","year":"2009","unstructured":"Akasaki Y, Matsuda S, Nakayama K, Fukagawa S, Miura H, Iwamoto Y (2009) Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation. Osteoarthritis Cartilage 17(2):235\u2013243","journal-title":"Osteoarthritis Cartilage"},{"key":"2008_CR69","unstructured":"Akasaki Y, Matsuda S, Iwamoto Y (2009) Progress of research in osteoarthritis. The anti-inflammatory effects of intra-articular injected statin on experimental osteoarthritis. Clin Calcium 19(11):1653\u20131662"},{"key":"2008_CR70","unstructured":"L\u00f3pez-Pedrera C, Ruiz-Lim\u00f3n P, Aguirre MA et al. (2010) Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome. Ann Rheum Dis 70(4):675\u2013682"},{"key":"2008_CR71","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1749-6632.2009.04815.x","volume":"1173","author":"P Jajoria","year":"2009","unstructured":"Jajoria P, Murthy V, Papalardo E, Romay-Penabad Z, Gleason C, Pierangeli SS (2009) Statins for the treatment of antiphospholipid syndrome? Ann N Y Acad Sci 1173:736\u2013745","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"2008_CR72","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","volume":"44","author":"PL Meroni","year":"2001","unstructured":"Meroni PL, Raschi E, Testoni C et al (2001) Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 44(12):2870\u20132878","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2008_CR73","first-page":"3453","volume":"118","author":"P Redecha","year":"2008","unstructured":"Redecha P, Franzke CW, Ruf W, Mackman N, Girardi G (2008) Neutrophil activation by the tissue factor\/factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest 118(10):3453\u20133461","journal-title":"J Clin Invest"},{"issue":"11","key":"2008_CR74","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1002\/art.11449","volume":"48","author":"DE Ferrara","year":"2003","unstructured":"Ferrara DE, Liu X, Espinola RG et al (2003) Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model. Arthritis Rheum 48(11):3272\u20133279","journal-title":"Arthritis Rheum"},{"key":"2008_CR75","unstructured":"Vasiuk IuA, Perlamutrov IuN, Shkol\u2019nik MN, Shkol\u2019nik EL (2010) Possibilities of atorvastatin in complex management of extensive psoriasis in patients with arterial hypertension. Kardiologiia. 50(3):37\u201346"},{"issue":"1","key":"2008_CR76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4314\/njm.v19i1.54216","volume":"19","author":"M Naseri","year":"2010","unstructured":"Naseri M, Hadipour A, Sepaskhah M, Namazi MR (2010) The remarkable beneficial effect of adding oral simvastatin to topical betamethasone for treatment of psoriasis: a double-blind, randomized, placebo-controlled study. Niger J Med 19(1):58\u201361","journal-title":"Niger J Med"},{"issue":"2","key":"2008_CR77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jjcc.2010.06.006","volume":"56","author":"A Hamaoka","year":"2010","unstructured":"Hamaoka A, Hamaoka K, Yahata T et al (2010) Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease. J Cardiol 56(2):245\u2013253","journal-title":"J Cardiol"},{"issue":"10","key":"2008_CR78","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1253\/circj.CJ-08-0121","volume":"72","author":"SM Huang","year":"2008","unstructured":"Huang SM, Weng KP, Chang JS et al (2008) Effects of statin therapy in children complicated with coronary arterial abnormality late after kawasaki disease: a pilot study. Circ J 72(10):1583\u20131587","journal-title":"Circ J"},{"issue":"5","key":"2008_CR79","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ard.2005.044503","volume":"65","author":"JC Denderen van","year":"2006","unstructured":"van Denderen JC, Peters MJ, van Halm VP et al (2006) Statin therapy might be beneficial for patients with ankylosing spondylitis. Ann Rheum Dis 65(5):695\u2013696","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2008_CR80","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1540-8175.2010.01180.x","volume":"27","author":"MT Inanc","year":"2010","unstructured":"Inanc MT, Kalay N, Heyit T et al (2010) Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Beh\u00e7et\u2019s disease. Echocardiography 27(8):997\u20131003","journal-title":"Echocardiography"},{"issue":"3","key":"2008_CR81","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10157-008-0029-6","volume":"12","author":"T Hashimoto","year":"2008","unstructured":"Hashimoto T, Toya Y, Kihara M et al (2008) Beh\u00e7et\u2019s disease complicated by IgA nephropathy with nephrotic syndrome. Clin Exp Nephrol 12(3):224\u2013227","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"2008_CR82","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/rheumatology\/keh194","volume":"43","author":"R ten Cate","year":"2004","unstructured":"ten Cate R, Nibbering PH, Bredius RG (2004) Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins. Rheumatology (Oxford) 43(7):934\u2013935","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2008_CR83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.amjmed.2003.10.033","volume":"116","author":"RS Rosenson","year":"2004","unstructured":"Rosenson RS (2004) Current overview of statin-induced myopathy. Am J Med 116(6):408\u2013416","journal-title":"Am J Med"},{"issue":"5","key":"2008_CR84","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/ard.2007.075523","volume":"67","author":"L Sailler","year":"2008","unstructured":"Sailler L, Pereira C, Bagheri A et al (2008) Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study. Ann Rheum Dis 67(5):614\u2013619","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2008_CR85","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/j.1756-185X.2010.01481.x","volume":"13","author":"D Sen","year":"2010","unstructured":"Sen D, Rosenstein ED, Kramer N (2010) ANCA-positive vasculitis associated with simvastatin\/ezetimibe: expanding the spectrum of statin-induced autoimmunity? Int J Rheum Dis 13(3):e29\u2013e31","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 2","key":"2008_CR86","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s10067-008-1020-z","volume":"27","author":"M Haroon","year":"2008","unstructured":"Haroon M, Devlin J (2008) A case of ANCA-associated systemic vasculitis induced by atorvastatin. Clin Rheumatol 27(Suppl 2):S75\u2013S77","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2008_CR87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","volume":"21","author":"B Noel","year":"2007","unstructured":"Noel B (2007) Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol 21(1):17\u201324","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2008_CR88","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10067-003-0772-8","volume":"23","author":"V Go\u00ebb","year":"2004","unstructured":"Go\u00ebb V, Guillemant N, Vittecoq O, Le Lo\u00ebt X (2004) Cerivastatin-induced polymyalgia rheumatica-like illness. Clin Rheumatol 23(2):179","journal-title":"Clin Rheumatol"},{"issue":"11","key":"2008_CR89","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1346-8138.2008.00558.x","volume":"35","author":"M Yamamoto","year":"2008","unstructured":"Yamamoto M, Ikeda M, Kodama H, Sano S (2008) Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology. J Dermatol 35(11):732\u2013736","journal-title":"J Dermatol"},{"issue":"5","key":"2008_CR90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2310\/7750.2010.09042","volume":"14","author":"AE Adams","year":"2010","unstructured":"Adams AE, Bobrove AM, Gilliam AC (2010) Statins and \u201cchameleon-like\u201d cutaneous eruptions: simvastatin-induced acral cutaneous vesiculobullous and pustular eruption in a 70-year-old man. J Cutan Med Surg 14(5):207\u2013211","journal-title":"J Cutan Med Surg"},{"key":"2008_CR91","unstructured":"Adams AE, Bobrove AM, Gilliam AC (2010) Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch rheumatoid arthritis monitoring (DREAM) registry. Ann Rheum Dis 70(5):877\u2013878"},{"key":"2008_CR92","unstructured":"Aronow C, Diamond B. A double blind, placebo controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. National Institute of Allergy and Infectious Diseases. Clinialtrials gov NCT00302952"},{"key":"2008_CR93","unstructured":"Ming Li EK. Effects of HMG-coA reductase inhibitor on progression of carotid intima-media thickness and arterial stiffness in rheumatoid arthritis. The Chinese University of Hong Kong. Clinicaltrial gov NCT00555230"},{"key":"2008_CR94","unstructured":"Ansell BJ. Effects of atorvastatin on disease activity and HDL cholesterol anti-inflammatory properties in patients with rheumatoid arthritis. The University of California, Los Angeles. Clinicatrial gov NCT00356473"},{"key":"2008_CR95","unstructured":"Pfizer, Inc. Phase 2 study of the effects of open-label CP-690,550 and double-blind atorvastatin on lipids in patients with active rheumatoid arthritis. Clinicaltrial gov NCT01059864"},{"key":"2008_CR96","unstructured":"Abdou NI. Statins and Lupus: effects of statins on clinical lupus parameters, serological markers and toll-like receptors. St. Luke\u2019s Hospital. Clinicaltrial gov NCT00519363"},{"key":"2008_CR97","unstructured":"Lai NS. An open labeled pilot study of atorvastatin in systemic lupus erythematosus. Buddhist Dalin Chi Tzu General Hospital. Clinicaltrial gov NCT00432354"},{"key":"2008_CR98","unstructured":"Schanberg LE. A multicenter, randomized, double-blind, placebo-controlled study to test the safety and efficacy of lipitor (atorvastatin) in reducing the progression of carotid IMT in early childhood SLE. Duke University. Clinicaltrial gov NCT00065806"},{"key":"2008_CR99","unstructured":"Belmont HM. Atorvastatin to prevent avascular necrosis of bone in steroid treated exacerbated systemic lupus erythematosus. New York University. Clinicaltrial gov NCT00412841"},{"key":"2008_CR100","unstructured":"Erkan D, Pierangeli S. Effects of fluvastatin on proinflammatory and prothrombotic markers in antiphospholipid syndrome patients. Hospital for Special Surgery. Clinicaltrial gov NCT00674297"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2008-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2008-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:48:32Z","timestamp":1712663312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,31]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2008-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,31]]}}}